4.7 Article

MRI Relaxometry for Quantitative Analysis of USPIO Uptake in Cerebral Small Vessel Disease

期刊

出版社

MDPI
DOI: 10.3390/ijms20030776

关键词

cerebral small vessel disease; MRI; ferumoxytol; USPIO; inflammation; relaxometry

资金

  1. Wellcome Trust-University of Edinburgh Institutional Strategic Support Fund
  2. University of Edinburgh Centre of Cognitive Ageing and Cognitive Epidemiology [G0700704/84698]
  3. Alzheimer's Society [252 (AS-PG-14-033)]
  4. European Union Horizon 2020 [666881]
  5. Row Fogo Charitable Trust [BRO-D.FID3668413]
  6. Fondation Leducq [16 CVD 05]
  7. UK Dementia Research Institute (Wardlaw Programme)
  8. Scottish Funding Council
  9. Chief Scientist Office of Scotland
  10. NHS Lothian Research and Development Office
  11. Stroke Association Princess Margaret Research Development Fellowship, Alzheimer Society [AS-PG-14-033]
  12. EU Horizon 2020 [666881]
  13. Garfield Weston Foundation Stroke Association Senior Clinical Lectureship
  14. NHS Research Scotland (NRS) fellowship from the Chief Scientist Office (Scotland)
  15. British Heart Foundation [CH/09/002, RE/13/3/30183, RM/13/2/30158]
  16. Wellcome Trust Senior Investigator Award [WT103782AIA]
  17. MRC [UKDRI-4002, MR/J006971/1, G0701127] Funding Source: UKRI

向作者/读者索取更多资源

A protocol for evaluating ultrasmall superparamagnetic particles of iron oxide (USPIO) uptake and elimination in cerebral small vessel disease patients was developed and piloted. B-1-insensitive R-1 measurement was evaluated in vitro. Twelve participants with history of minor stroke were scanned at 3-T MRI including structural imaging, and R-1 and R-2* mapping. Participants were scanned (i) before and (ii) after USPIO (ferumoxytol) infusion, and again at (iii) 24-30 h and (iv) one month. Absolute and blood-normalised changes in R-1 and R-2* were measured in white matter (WM), deep grey matter (GM), white matter hyperintensity (WMH) and stroke lesion regions. R-1 measurements were accurate across a wide range of values. R-1 (p < 0.05) and R-2* (p < 0.01) mapping detected increases in relaxation rate in all tissues immediately post-USPIO and at 24-30 h. R-2* returned to baseline at one month. Blood-normalised R-1 and R-2* changes post-infusion and at 24-30 h were similar, and were greater in GM versus WM (p < 0.001). Narrower distributions were seen with R-2* than for R-1 mapping. R-1 and R-2* changes were correlated at 24-30 h (p < 0.01). MRI relaxometry permits quantitative evaluation of USPIO uptake; R-2* appears to be more sensitive to USPIO than R-1. Our data are explained by intravascular uptake alone, yielding estimates of cerebral blood volume, and did not support parenchymal uptake. Ferumoxytol appears to be eliminated at 1 month. The approach should be valuable in future studies to quantify both blood-pool USPIO and parenchymal uptake associated with inflammatory cells or blood-brain barrier leak.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850)

Philip M. Bath, Iris Mhlanga, Lisa J. Woodhouse, Fergus Doubal, Katherine Oatey, Alan A. Montgomery, Joanna M. Wardlaw

Summary: The study is a feasibility study to evaluate the effectiveness of silostazol and isosorbide mononitrate in preventing the progression of cerebral small vessel disease (SVD). This study is of great importance for the prevention and treatment of SVD.

STROKE AND VASCULAR NEUROLOGY (2023)

Article Clinical Neurology

Measures of intracranial compartments in acute intracerebral haemorrhage: data from the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke-2 Trial (RIGHT-2)

Kailash Krishnan, Zhe Kang Law, Lisa J. Woodhouse, Rob A. Dineen, Nikola Sprigg, Joanna M. Wardlaw, Philip M. Bath

Summary: In this study, measures of intracranial compartments in acute intracerebral haemorrhage (ICH) were assessed using computerised tomography scans. The study found that ICH volume adjusted for intracranial and cerebral parenchymal volume could be useful in predicting functional outcomes in acute stroke. Additionally, midline shift and cistern effacement may predict outcome but further validation is needed.

STROKE AND VASCULAR NEUROLOGY (2023)

Letter Cardiac & Cardiovascular Systems

Impact of Patient Selection on Performance of an Early Rule-Out Pathway for Myocardial Infarction: From Research to the Real World

Anda Bularga, Kuan Ken Lee, Anoop S. V. Shah, Atul Anand, Andrew R. Chapman, Chris Tuck, David E. Newby, Sarah Jenks, Nicholas L. Mills, Dorien M. Kimenai

CIRCULATION (2023)

Review Cardiac & Cardiovascular Systems

Imaging of intracoronary thrombus

Beth Whittington, Evangelos Tzolos, Michelle C. Williams, Marc R. Dweck, David E. Newby

Summary: The identification of intracoronary thrombus and atherothrombosis is crucial for diagnosing acute myocardial infarction. Invasive coronary angiography remains the primary imaging modality, but more recent non-invasive angiographic techniques like CT and MRI have improved visualisation of coronary artery disease. Invasive intravascular imaging approaches, such as angioscopy, intravascular ultrasound, and optical coherence tomography, provide direct visualisation of coronary atheroma and better thrombus detection. Non-invasive detection of intracoronary thrombus using radiotracers holds promise but has not been widely implemented in routine clinical practice.
Article Cardiac & Cardiovascular Systems

Coronary low-attenuation plaque and high-sensitivity cardiac troponin

Mohammed N. Meah, Ryan Wereski, Anda Bularga, Edwin J. R. van Beek, Marc R. Dweck, Nicholas L. Mills, David E. Newby, Damini Dey, Michelle Claire Williams, Kuan Ken Lee

Summary: In patients with acute chest pain, plasma cardiac troponin I concentrations >= 5 ng/L, even without myocardial infarction, are associated with a higher burden of low-attenuation coronary plaque. This suggests that cardiac troponin may be indicative of future adverse cardiovascular events in these patients.
Article Cardiac & Cardiovascular Systems

Cost-effectiveness of rapid assessment of potential ischaemic heart disease with CT coronary angiography

Praveen Thokala, Steve Goodacre, Katherine Oatey, Rachel O'Brien, David E. Newby, Alasdair Gray

Summary: This study aimed to estimate the cost-effectiveness of early CT coronary angiography (CTCA) for intermediate risk patients with suspected acute coronary syndrome (ACS), compared with standard care. The results showed that within the trial, there were no significant differences in costs or QALYs between early CTCA and standard care. Long-term economic analysis suggested higher long-term costs with CTCA and uncertain effect on long-term QALYs, making routine use of CTCA for suspected ACS unlikely to be a cost-effective use of NHS resources.
Article Cardiac & Cardiovascular Systems

Genetic analyses identify brain structures related to cognitive impairment associated with elevated blood pressure

Mateusz Siedlinski, Lorenzo Carnevale, Xiaoguang Xu, Daniela Carnevale, Evangelos Evangelou, Mark J. Caulfield, Pasquale Maffia, Joanna Wardlaw, Nilesh J. Samani, Maciej Tomaszewski, Giuseppe Lembo, Michael Holmes, Tomasz J. Guzik

Summary: Observational and genetic data were used to study the relationship between blood pressure and cognitive function. The study identified brain structures associated with blood pressure and found that higher systolic blood pressure may have an adverse effect on cognitive function. These findings contribute to our understanding of the negative impact of hypertension on cognitive performance.

EUROPEAN HEART JOURNAL (2023)

Article Endocrinology & Metabolism

Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease

Salvatore Rudilosso, Michael S. Stringer, Michael Thrippleton, Francesca Chappell, Gordon W. Blair, Daniela Jaime Garcia, Fergus Doubal, Iona Hamilton, Esther Janssen, Anna Kopczak, Michael Ingrisch, Danielle Kerkhofs, Walter H. Backes, Julie Staals, Marco Duering, Martin Dichgans, Joanna M. Wardlaw

Summary: Blood-brain barrier impairment is common in cerebral small vessel disease, and its relationship with SVD lesions was investigated using DCE-MRI in a cohort of 69 patients. The study found that SVD lesions frequently collocate with high BBB-leakage in patients with both sporadic and monogenic forms of SVD. The presence and number of BBB-leakage hotspots were associated with factors such as WMH-CVR and WMH volume.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2023)

Article Endocrinology & Metabolism

Visualising and semi-quantitatively measuring brain fluid pathways, including meningeal lymphatics, in humans using widely available MRI techniques

Stefan Sennfalt, Michael J. Thrippleton, Michael Stringer, Carmen Arteaga Reyes, Francesca Chappell, Fergus Doubal, Daniela J. Garcia, Junfang Zhang, Yajun Cheng, Joanna Wardlaw

Summary: This study investigates brain fluid outflow pathways using MRI techniques and finds that these pathways can be visualized using conventional MRI. The results suggest that interstitial fluid drains via cortical perivenous spaces and are associated with small vessel disease.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2023)

Article Biochemistry & Molecular Biology

Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations

Dimitrios M. Doudesis, Kuan Ken Lee, Jasper Boeddinghaus, Anda Bularga, Amy E. Ferry, Chris D. Tuck, Matthew T. H. Lowry, Pedro Lopez-Ayala, Thomas Nestelberger, Luca E. Koechlin, Miguel Bernabeu, Lis Neubeck, Atul Anand, Karen Schulz, Fred Apple, William J. Parsonage, Jaimi Greenslade, Louise Cullen, John Pickering, Martin O. Than, Alasdair Gray, Christian W. Mueller, Nicholas Mills, CoDE-ACS Investigators

Summary: A clinical decision support system using machine learning models and high-sensitivity troponin measurements outperforms clinical guidelines that use fixed cardiac troponin thresholds for myocardial infarction diagnosis. The system integrates cardiac troponin concentrations and clinical features to calculate CoDE-ACS score, which corresponds to an individual's probability of myocardial infarction. It has excellent discrimination for myocardial infarction, identifies more low probability cases and reduces cardiac death rate.

NATURE MEDICINE (2023)

Review Biochemistry & Molecular Biology

A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies

Daniela Jaime Garcia, Audrey Chagnot, Joanna M. Wardlaw, Axel Montagne

Summary: Small vessel disease (SVD) is a prevalent disorder of the brain's microvessels and is a common cause of dementia and strokes. Recent evidence suggests that endothelial dysfunction and a compromised blood-brain barrier play a key role in the development and progression of SVD. Understanding the molecular mechanisms underlying endothelial dysfunction in SVD could lead to better diagnostic tools and potential therapeutic interventions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Clinical Neurology

Paranasal sinuses opacification on magnetic resonance imaging in relation to brain health in sporadic small vessel disease-Systematic review and pilot analysis

Alba Saenz de Villaverde Cortabarria, Jun-Fang Zhang, Maria del C. Valdes Hernandez, Una Clancy, Eleni Sakka, Karen J. Ferguson, Stewart Wiseman, Will Hewins, Daniela Jaime Garcia, Michael Stringer, Michael Thrippleton, Francesca Chappell, Fergus Doubal, Yun-Cheng Wu, Joanna M. Wardlaw

Summary: This study examines the potential association between paranasal sinus mucosal changes and small vessel disease (SVD). By reviewing the literature and analyzing a sample of SVD patients, it was found that the severity of paranasal sinus opacification may be related to neuroimaging markers of SVD.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2023)

Review Clinical Neurology

Neuroimaging standards for research into small vessel disease-advances since 2013

Marco Duering, Geert Jan Biessels, Amy Brodtmann, Christopher Chen, Charlotte Cordonnier, Frank-Erik de Leeuw, Stephanie Debette, Richard Frayne, Eric Jouvent, Natalia S. Rost, Annemieke ter Telgte, Rustam Al-Shahi Salman, Walter H. Backes, Hee-Joon Bae, Rosalind Brown, Hugues Chabriat, Alberto De Luca, Charles deCarli, Anna Dewenter, Fergus N. Doubal, Michael Ewers, Thalia S. Field, Aravind Ganesh, Steven Greenberg, Karl G. Helmer, Saima Hilal, Angela C. C. Jochems, Hanna Jokinen, Hugo Kuijf, Bonnie Y. K. Lam, Jessica Lebenberg, Bradley J. MacIntosh, Pauline Maillard, Vincent C. T. Mok, Leonardo Pantoni, Salvatore Rudilosso, Claudia L. Satizabal, Markus D. Schirmer, Reinhold Schmidt, Colin Smith, Julie Staals, Michael J. Thrippleton, Susanne J. van Veluw, Prashanthi Vemuri, Yilong Wang, David Werring, Marialuisa Zedde, Rufus O. Akinyemi, Oscar H. Del Brutto, Hugh S. Markus, Yi-Cheng Zhu, Eric E. Smith, Martin Dichgans, Joanna M. Wardlaw

Summary: Cerebral small vessel disease (SVD) is a common age-related condition that can cause stroke, cognitive decline, neurobehavioral symptoms, and functional impairment. STRIVE-1 classified and standardized the various visible features of SVD on structural MRI, but new information and imaging techniques have emerged since then. Quantitative imaging biomarkers and machine learning methods offer a more comprehensive understanding of the impact of SVD on the brain and can serve as intermediary outcomes in clinical trials and routine practice.

LANCET NEUROLOGY (2023)

暂无数据